China Doubles Budget For Biopharma Sector To RMB 40 Billion In 2011-15
This article was originally published in PharmAsia News
Executive Summary
Beijing plans to double its RMB 17.8 billion appropriation for the biopharmaceutical industry in its 11th Five-Year Plan to RMB 40 billion in the 12th Five-Year Plan, an authority revealed